Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04661046Unknown
Trial of bazhengsan in colorectal cancer (CRC), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoints: Overall Survival at 2 years and Progression Free Survival at 2 years. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04661046.